These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22646697)

  • 1. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity.
    Ilves T; Harvima IT
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e197-205. PubMed ID: 22646697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
    Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis.
    Elsner JS; Carlsson M; Stougaard JK; Nygaard U; Buchner M; Fölster-Holst R; Hvid M; Vestergaard C; Deleuran M; Deleuran B
    Acta Derm Venereol; 2020 Mar; 100(6):adv00099. PubMed ID: 32176307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].
    Zhu R; Jiang J; Wang T; Xu T; Wu M; Liu C; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):862-5. PubMed ID: 23948416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.
    Sadrolashrafi K; Guo L; Kikuchi R; Hao A; Yamamoto RK; Tolson HC; Bilimoria SN; Yee DK; Armstrong AW
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
    Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
    Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.
    Croft M; Esfandiari E; Chong C; Hsu H; Kabashima K; Kricorian G; Warren RB; Wollenberg A; Guttman-Yassky E
    Am J Clin Dermatol; 2024 May; 25(3):447-461. PubMed ID: 38236520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Atopic Dermatitis: Current Paradigm.
    Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
    Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells.
    Yan J; Wang C; Du R; Liu P; Chen G
    Chem Biol Interact; 2009 Aug; 180(3):460-4. PubMed ID: 19416722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
    Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
    Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection.
    Wang YL; Fu YX; Zhu ZJ; Wang H; Shen ZY
    Chin Med J (Engl); 2012 Nov; 125(21):3786-90. PubMed ID: 23106874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway wall expression of OX40/OX40L and interleukin-4 in asthma.
    Siddiqui S; Mistry V; Doe C; Stinson S; Foster M; Brightling C
    Chest; 2010 Apr; 137(4):797-804. PubMed ID: 20139223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
    Ishii N; Takahashi T; Soroosh P; Sugamura K
    Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
    Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
    Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OX40-OX40L expression in idiopathic inflammatory myopathies.
    Papadopoulos C; Terzis G; Papadimas GK; Manta P
    Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):17-26. PubMed ID: 23469620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C.
    Zhang JY; Wu XL; Yang B; Wang Y; Feng GH; Jiang TJ; Zeng QL; Xu XS; Li YY; Jin L; Lv S; Zhang Z; Fu J; Wang FS
    Eur J Immunol; 2013 Jul; 43(7):1953-62. PubMed ID: 23589118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic dermatitis in adults: evaluation of peripheral blood mononuclear cells proliferation response to Staphylococcus aureus enterotoxins A and B and analysis of interleukin-18 secretion.
    Orfali RL; Sato MN; Takaoka R; Azor MH; Rivitti EA; Hanifin JM; Aoki V
    Exp Dermatol; 2009 Jul; 18(7):628-33. PubMed ID: 19469892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.